• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病运动功能障碍的无监督亚型分类及其脑结构成像相关性。

Unsupervised subtyping of motor dysfunction of Parkinson's disease and its structural brain imaging correlates.

作者信息

Lin Yu-Fan, Fuh Jong-Ling, Yang Albert C

机构信息

School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.

Division of General Neurology, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan.

出版信息

Neuroimage Rep. 2025 Mar 1;5(1):100246. doi: 10.1016/j.ynirp.2025.100246. eCollection 2025 Mar.

DOI:10.1016/j.ynirp.2025.100246
PMID:40567892
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12172897/
Abstract

BACKGROUND

Parkinson's disease (PD) is a clinical neurodegenerative disorder. The Unified Parkinson's Disease Rating Scale (UPDRS) has been used as a standard measure of the PD symptom profile, and magnetic resonance (MR) imaging is widely used for identifying the critical brain regions involved in PD progression.

OBJECTIVES

The present study aimed to (1) identify PD subtypes based on the motor dysfunction profile in the MDS-UPDRS and (2) find the differences in gray matter volumes of brain regions, and (3) compare non-motor features between the subtypes to explore their distinct clinical profiles.

METHODS

In total, 299 patients with PD and 173 healthy participants from the Parkinson's Progression Markers Initiative were included. A software package, Generalized Association Plots, was used to cluster the motor dysfunction profile in the MDS-UPDRS. Regression models and the Artificial Intelligence Platform as a Service were used to quantify the differences in gray matter volume of brain regions between subtypes.

RESULTS

We identified three PD subtypes-resting tremor, intermediate, and akinetic-rigid-using motor symptom clustering. MRI analysis revealed significant differences in brain regions, including the posterior cingulate gyrus, lenticular nucleus, olfactory cortex, and cerebellum. Non-motor features, such as cognitive decline and autonomic dysfunctions, varied across subtypes, highlighting distinct systemic profiles. Akinetic-rigid patients exhibited the most severe impairments, while tremor-dominant patients showed milder non-motor symptoms.

DISCUSSION

Three PD subtypes of motor dysfunction were identified. Structural brain imaging revealed subtype-specific differences not only in cingulum and putamen regions, but also in the olfactory cortex, parahippocampal gyrus, and cerebellum, correlating with motor symptoms. Non-motor features varied by subtype, with increasing severity from tremor-dominant to akinetic-rigid.

摘要

背景

帕金森病(PD)是一种临床神经退行性疾病。统一帕金森病评定量表(UPDRS)一直被用作衡量PD症状特征的标准指标,而磁共振(MR)成像广泛用于识别参与PD进展的关键脑区。

目的

本研究旨在(1)基于MDS-UPDRS中的运动功能障碍特征识别PD亚型,(2)找出脑区灰质体积的差异,以及(3)比较各亚型之间的非运动特征,以探索它们不同的临床特征。

方法

总共纳入了帕金森病进展标志物倡议项目中的299例PD患者和173名健康参与者。使用一个名为广义关联图的软件包对MDS-UPDRS中的运动功能障碍特征进行聚类。使用回归模型和人工智能平台即服务来量化各亚型之间脑区灰质体积的差异。

结果

我们通过运动症状聚类识别出三种PD亚型——静止性震颤型、中间型和运动不能-强直型。MRI分析显示脑区存在显著差异,包括后扣带回、豆状核、嗅觉皮层和小脑。认知衰退和自主神经功能障碍等非运动特征在各亚型中有所不同,突出了不同的系统特征。运动不能-强直型患者表现出最严重的损伤,而震颤为主型患者的非运动症状较轻。

讨论

识别出了三种运动功能障碍的PD亚型。脑结构成像显示,不仅在扣带和壳核区域,而且在嗅觉皮层、海马旁回和小脑中存在亚型特异性差异,这些差异与运动症状相关。非运动特征因亚型而异,从震颤为主型到运动不能-强直型严重程度逐渐增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1451/12172897/f0d2922c617b/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1451/12172897/bf0ffc3e18f6/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1451/12172897/411055498e62/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1451/12172897/0a55512a8677/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1451/12172897/f0d2922c617b/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1451/12172897/bf0ffc3e18f6/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1451/12172897/411055498e62/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1451/12172897/0a55512a8677/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1451/12172897/f0d2922c617b/gr4.jpg

相似文献

1
Unsupervised subtyping of motor dysfunction of Parkinson's disease and its structural brain imaging correlates.帕金森病运动功能障碍的无监督亚型分类及其脑结构成像相关性。
Neuroimage Rep. 2025 Mar 1;5(1):100246. doi: 10.1016/j.ynirp.2025.100246. eCollection 2025 Mar.
2
Distinct brain atrophy progression subtypes underlie phenoconversion in isolated REM sleep behaviour disorder.不同的脑萎缩进展亚型是孤立性快速眼动睡眠行为障碍中表型转换的基础。
EBioMedicine. 2025 May 29;117:105753. doi: 10.1016/j.ebiom.2025.105753.
3
Depressive symptoms can negatively influence patient reported disease severity after subthalamic nucleus stimulation for Parkinson's disease.对于帕金森病患者,在接受丘脑底核刺激后,抑郁症状会对患者报告的疾病严重程度产生负面影响。
J Parkinsons Dis. 2025 Jun 26:1877718X251354933. doi: 10.1177/1877718X251354933.
4
Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis.帕金森病患者的体育锻炼:系统评价与网状Meta分析
Cochrane Database Syst Rev. 2024 Apr 8;4(4):CD013856. doi: 10.1002/14651858.CD013856.pub3.
5
Unveiling the neural network of freezing of gait in Parkinson's disease: A coordinate-based network study.揭示帕金森病步态冻结的神经网络:一项基于坐标的网络研究。
J Parkinsons Dis. 2025 Jun 19:1877718X251348669. doi: 10.1177/1877718X251348669.
6
Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis.帕金森病患者的身体锻炼:系统评价和网络荟萃分析。
Cochrane Database Syst Rev. 2023 Jan 5;1(1):CD013856. doi: 10.1002/14651858.CD013856.pub2.
7
Modulation of Cerebellar Oscillations with Subthalamic Stimulation in Patients with Parkinson's Disease.小脑刺激对帕金森病患者的调节。
J Parkinsons Dis. 2024;14(7):1417-1426. doi: 10.3233/JPD-240065.
8
Intestinal biomarkers, microbiota composition, and genetic predisposition to inflammatory bowel disease as predictors of Parkinson's disease manifestation.肠道生物标志物、微生物群组成以及炎症性肠病的遗传易感性作为帕金森病表现的预测指标。
J Parkinsons Dis. 2025 May 7:1877718X251328567. doi: 10.1177/1877718X251328567.
9
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.用于路易体痴呆、帕金森病痴呆及帕金森病认知障碍的胆碱酯酶抑制剂
Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD006504. doi: 10.1002/14651858.CD006504.pub2.
10
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.

本文引用的文献

1
Parkinson's Disease Subtyping Using Clinical Features and Biomarkers: Literature Review and Preliminary Study of Subtype Clustering.利用临床特征和生物标志物对帕金森病进行亚型分类:文献综述与亚型聚类的初步研究
Diagnostics (Basel). 2022 Jan 4;12(1):112. doi: 10.3390/diagnostics12010112.
2
Classification of PPMI MRI scans with voxel-based morphometry and machine learning to assist in the diagnosis of Parkinson's disease.利用基于体素的形态测量和机器学习对PPMI MRI扫描进行分类以辅助帕金森病的诊断。
Comput Methods Programs Biomed. 2021 Jan;198:105793. doi: 10.1016/j.cmpb.2020.105793. Epub 2020 Oct 15.
3
Essential tremor severity and anatomical changes in brain areas controlling movement sequencing.
震颤严重程度与控制运动序列的脑区解剖变化。
Ann Clin Transl Neurol. 2018 Nov 8;6(1):83-97. doi: 10.1002/acn3.681. eCollection 2019 Jan.
4
Prognosis and Neuropathologic Correlation of Clinical Subtypes of Parkinson Disease.帕金森病临床亚型的预后与神经病理学相关性。
JAMA Neurol. 2019 Apr 1;76(4):470-479. doi: 10.1001/jamaneurol.2018.4377.
5
The Parkinson's progression markers initiative (PPMI) - establishing a PD biomarker cohort.帕金森病进展标志物计划(PPMI)——建立帕金森病生物标志物队列。
Ann Clin Transl Neurol. 2018 Oct 31;5(12):1460-1477. doi: 10.1002/acn3.644. eCollection 2018 Dec.
6
The cerebellum and cognition.小脑与认知。
Neurosci Lett. 2019 Jan 1;688:62-75. doi: 10.1016/j.neulet.2018.07.005. Epub 2018 Jul 8.
7
Consistent decreased activity in the putamen in Parkinson's disease: a meta-analysis and an independent validation of resting-state fMRI.帕金森病壳核静息态功能磁共振成像的一致性低活动:荟萃分析和独立验证。
Gigascience. 2018 Jun 1;7(6). doi: 10.1093/gigascience/giy071.
8
Olfactory Dysfunction as an Early Biomarker in Parkinson's Disease.嗅觉功能障碍作为帕金森病的早期生物标志物。
Neurosci Bull. 2017 Oct;33(5):515-525. doi: 10.1007/s12264-017-0170-x. Epub 2017 Aug 22.
9
Magnetic resonance imaging for the diagnosis of Parkinson's disease.用于帕金森病诊断的磁共振成像
J Neural Transm (Vienna). 2017 Aug;124(8):915-964. doi: 10.1007/s00702-017-1717-8. Epub 2017 Apr 4.
10
Subtypes of Parkinson's Disease: What Do They Tell Us About Disease Progression?帕金森病的亚型:它们能告诉我们疾病进展的情况吗?
Curr Neurol Neurosci Rep. 2017 Apr;17(4):34. doi: 10.1007/s11910-017-0738-x.